We are live on
!
Find out more
CCM
Carderock Capital Management Portfolio holdings
AUM
$456M
1-Year Est. Return
31.89%
This Fund
S&P 500
This Quarter
Est. Return
+11.78%
1 Year Est. Return
+31.89%
3 Year Est. Return
+88.65%
5 Year Est. Return
+111.4%
10 Year Est. Return
+513.53%
AUM
$241M
AUM Growth
+$45.2M
(+23%)
Cap. Flow
+$24.9M
Cap. Flow
% of AUM
10.34%
Top 10 Holdings %
Top 10 Hldgs %
34.41%
Holding
68
New
3
Increased
32
Reduced
23
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$5.34M |
| 2 |
IDEX
IEX
|
+$3.74M |
| 3 |
Mastercard
MA
|
+$3.62M |
| 4 |
Estee Lauder
EL
|
+$3.46M |
| 5 |
Honeywell
HON
|
+$2.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$2.84M |
| 2 |
TSMC
TSM
|
+$1.57M |
| 3 |
Revvity
RVTY
|
+$1.55M |
| 4 |
Generac Holdings
GNRC
|
+$853K |
| 5 |
Adobe
ADBE
|
+$715K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.19% |
| 2 | Healthcare | 16.04% |
| 3 | Industrials | 14.8% |
| 4 | Financials | 11.41% |
| 5 | Consumer Staples | 7.91% |
Similar funds
HFF
FIM
EGP
AWM
EIA
BRF
TCMP
FC
Carderock Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Carderock Capital Management held 68 positions worth $241M, up 23% from $196M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Carderock Capital Management deployed $24.9M of net new capital in Q4 2022, opening 3 new positions and adding to 32 existing holdings. Its largest new stake was UnitedHealth: 10,077 shares worth $5.34M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 33% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was TSMC, an estimated $1.57M trimmed.
- Carderock Capital Management's largest Q4 2022 buy was UnitedHealth: 10,077 shares worth $5.34M.
- Carderock Capital Management added most to Mastercard in Q4 2022, an estimated $3.62M increase.
- Carderock Capital Management's biggest Q4 2022 reduction was TSMC, cutting an estimated $1.57M.
- Carderock Capital Management fully exited Edwards Lifesciences in Q4 2022, selling an estimated $2.84M.
- Carderock Capital Management's ten largest holdings make up 34% of its $241M portfolio in Q4 2022.
- Carderock Capital Management opened 3 new positions and closed 4 in Q4 2022.
- Carderock Capital Management's portfolio value rose 23% quarter-over-quarter to $241M.
Based on Carderock Capital Management's 13F filing for Q4 2022, filed 20 Jan 2023.